Sciatic Nerve Block
Sciatic nerve block may represent an effective complement to femoral nerve block for total knee arthroplasty.
The use of staged bilateral continuous femoral nerve blockade and single-injection sciatic nerve blockade with single-injection subarachnoid block may effectively control pain following bilateral total knee arthroplasty.
Adding a sciatic nerve block to a continuous femoral nerve block after total hip arthroplasty significantly reduces pain.
In patients undergoing total knee arthroplasty, sciatic nerve block plus femoral nerve block was more effective for pain relief than local infiltration analgesia plus femoral nerve block.
Sciatic Nerve Block Plus Femoral Nerve Block May Provide Superior Pain Relief After Total Knee ArthroplastyMay 24, 2017
The meta-analysis indicated that sciatic plus femoral nerve blocks provide analgesia superior to local infiltration combined with femoral nerve block at 24 and 48 hours following TKA.
Clinical Pain Advisor Articles
- Deaths After Nonfatal Opioid Overdose: Causes and Risk Factors
- Treatment for Opioid Use Disorder Associated With Reduced Risk for Opioid-Related Deaths
- Opioid-Free Analgesia Use for Postsurgical Pain Limited
- Clonidine May Not Improve Post-Cesarean Delivery Analgesia
- No Added Value With Liposomal Bupivacaine Following TKA With Peripheral Nerve Block
- Recommendations for Perioperative Pain Management in Patients With Opioid Tolerance
- Vertebroplasty Comparable With Placebo for Acute Vertebral Compression Fractures
- Capsaicin 8% Patch May Be Effective in Neuropathic Pain
- Detox vs Medication-Assisted Treatment for Opioid Use Disorder in Pregnancy: Expert Roundtable
- Prior Authorization Policy May Help Reduce Long-Acting Opioid Use
- Opioid-Related Deaths Represent Significant Public Health Burden
- Addressing Confidentiality Concerns With Electronic Access to Pediatric Medical Records
- Opioid-Related Adverse Events Common After Invasive Procedures
- Diagnosis and Treatment of Migraine in Children Should Consider Atopy
- Led by AG Sessions, DOJ Declines to Defend ACA Against Federal Lawsuit